The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

dymind.com.cn

Total Raised

$106.29M

Investors Count

10

Dimai Biotech Funding, Dimai Biotech Valuation & Dimai Biotech Revenue

4 Fundings

Dimai Biotech's latest funding round was a Series C for $100M on December 17, 2020.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

12/17/2020

Series C

$100M

0

FY undefined

1

4/15/2018

Series A

0

FY undefined

10

5/4/2017

Seed

0

FY undefined

10

1/1/2016

Corporate Minority

$99M

0

FY undefined

10

Date

12/17/2020

4/15/2018

5/4/2017

1/1/2016

Round

Series C

Series A

Seed

Corporate Minority

Amount

$100M

$99M

Investors

Valuation

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

1

10

10

10

Dimai Biotech Investors

10 Investors

Dimai Biotech has 10 investors. Kaiser Permanente Ventures invested in Dimai Biotech's Series C funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

12/17/2020

12/17/2020

1
Series C

Corporate Venture

California

12/17/2020

12/17/2020

1
Series C

Venture Capital

China

12/17/2020

12/17/2020

1
Series C

Venture Capital

China

00/00/0000

00/00/0000

Eli Lilly and Company

Subscribe to see more

Corporation

Indiana

00/00/0000

00/00/0000

Vivo Capital

Subscribe to see more

Venture Capital

California

First funding

12/17/2020

12/17/2020

12/17/2020

00/00/0000

00/00/0000

Last Funding

12/17/2020

12/17/2020

12/17/2020

00/00/0000

00/00/0000

Investor

Eli Lilly and Company

Vivo Capital

Rounds

1
Series C
1
Series C
1
Series C

Subscribe to see more

Subscribe to see more

Board Seats

Type

Corporate Venture

Venture Capital

Venture Capital

Corporation

Venture Capital

Location

California

China

China

Indiana

California

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.